BioCorRx Inc.
BICX
$0.35
-$0.0594-14.51%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.32% | 31.97% | -20.25% | -71.70% | -31.97% |
| Total Depreciation and Amortization | 251.50% | 3.90% | -74.11% | -58.07% | -38.20% |
| Total Amortization of Deferred Charges | -67.11% | -43.44% | -1.50% | 46.79% | 183.96% |
| Total Other Non-Cash Items | -55.09% | 46.71% | 713.23% | 757.16% | -13.72% |
| Change in Net Operating Assets | 48.27% | -191.13% | 338.03% | -16.85% | 691.96% |
| Cash from Operations | 16.72% | -103.00% | 53.69% | -2.00% | 73.42% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 260.67% | 68.42% | -21.14% | 15.68% | 11,800.00% |
| Total Debt Repaid | 0.00% | -1,750.00% | -500.00% | -3,033.33% | 98.87% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 261.82% | 66.63% | -24.29% | 12.79% | -89.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 194.61% | -277.99% | 196.38% | 79.71% | -1,348.44% |